Concepedia
4
Publications
90
Citations
H-Index
2021
Active since
Affiliations
China Pharmaceutical University(Current)
Nantong University
Affiliated Hospital of Nantong University
First Affiliated Hospital of Zhengzhou University
Guiyuan Xiang is an author at China Pharmaceutical University.
Publications per year
2021–2023
First-line atezolizumab plus chemotherapy in advanced non-squamous non-small cell lung cancer: a cost-effectiveness analysis from China
Zhiguang Yang, Yumei Zhu, Guiyuan Xiang et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2021 · 40 citations
Economic Evaluation of First-Line Camrelizumab for Advanced Non-small-cell Lung Cancer in China
Guiyuan Xiang, Lingna Gu, Xuan Chen et al. · Frontiers in Public Health · 2021 · 23 citations · Full text
Cost-effectiveness of serplulimab as first-line therapy for extensive-stage small cell lung cancer in China
Guiyuan Xiang, Tingting Jiang, Lanlan Gan et al. · Frontiers in Immunology · 2023 · 17 citations · Full text
Durvalumab consolidation therapy in patients with stage III non-small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysis
Xuan Chen, Zhiguang Yang, Guiyuan Xiang et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2021 · 10 citations
Rows per page
1–4 of 4